Drugs / ADVAX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00902824 Comparator | Nov 2008 → Apr 2010 | HIV infectious disease | International AIDS Vaccine Initiative | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADVAX | “Receive 4mg ADVAX at Months 0, 1, and 2 (Biojector), and receive boost of 5x10\^7 pfu TBC-M4 (IM)” NCT00902824 ↗ |
| Modality | Vaccine | “ADVAX, DNA HIV Vaccine” NCT00902824 ↗ |
| Route | Other | “via Biojector” NCT00902824 ↗ |